Health

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited ( www.camheartwear.com

2026-10-07 01:00 3282

XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling

* This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental workflow, pioneering in vivo efficacy prediction models to accelerate drug developme...

2026-10-06 22:42 3826

Hisun Pharmaceutical Celebrates 70th Anniversary with Global Partners at Milan-Taizhou Night

MILAN, Oct. 6, 2026 /PRNewswire/ -- Zhejiang Hisun Pharmaceutical Co., Ltd. hosted its 70th Anniversary Global Partners Appreciation Dinner in Milan on October 5, the eve of CPHI Milan 2026. Themed "Bridging Cultures, Advancing Health Together," the event brought together leading pharmaceutical c...

2026-10-06 21:32 1493

/C O R R E C T I O N -- Piramal Pharma Solutions/

In the news release, Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility, issued 06-Oct-2026 by Piramal Pharma Solutions over PR Newswire, we are advised by the company that changes have been made to the caption accompanying the first ima...

2026-10-06 16:59 2292

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral-Care Innovation Rooted in Trans-Pacific Alder Research

Botanical oral-care product bridges 1974 Oregon State University discovery of 'oregonin' with 27 years of natural-product research by South Korean scientists. SEOUL, South Korea, Oct. 6, 2026 /PRNewswire/ -- Dr. Oregonin Inc. today announced that it has completed U.S. Food and Drug Administration...

2026-10-06 13:50 1996

Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue

Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period BEIJING, Oct. 5, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic in...

2026-10-05 22:13 4971

OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.

* OMLYCLO® (omalizumab-igec) is the first and onlyFDA-approved omalizumab biosimilar approved for all four indications of XOLAIR® (omalizumab) and designated as interchangeable with XOLAIR; OMLYCLO® will be available in 75 mg/0.5 mL, 150 mg/mL and 300mg/2mL in a single-dose prefilled syringe fo...

2026-10-05 20:45 3049

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea

TAIPEI, Oct. 5, 2026 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with Yoo Young Pharm. Co., Ltd. ("YYP"), a South Korea-based pharmaceutical company, to explore a collaboration for the development, registra...

2026-10-05 18:00 2063

Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care AUCKLAND, New Zealand, Oct. 5, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a prospec...

2026-10-05 12:46 2173

Celaid Therapeutics Completes Second Close of Series B Financing Round

Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate  U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the complet...

2026-10-05 09:30 1568

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

* First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. * Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression,...

2026-10-03 19:30 6045

/DISREGARD RELEASE: Jiangsu Vcare/

We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire. ...

2026-10-02 19:12 4760

Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference

STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that representatives from the Company's management and investor relations teams will participate in the 17th Annual Craig-Ha...

2026-10-02 18:30 5787

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager Agreement also gives Novartis exclusive options to license other potential programs leveraging Abogen's RNA proprietary platform SUZHOU, China, Oct. 2, 2026 /PRNewswire/ -- Abogen Biosciences ("Abogen" or the ...

2026-10-02 12:42 2992

I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026"

PALO ALTO, Calif., Oct. 1, 2026 /PRNewswire/ -- I Peace Inc., a biotech company pioneering induced pluripotent stem cell (iPScell) technologies for regenerative medicine and longevity, today announced that it was selected as one of the awardees for the Top 10 Longevity Breakthrough Awards at the ...

2026-10-02 06:10 1815

Momcozy Announces $100,000 Scholarship Fund to Expand Access to Perinatal Mental Health Certification

LOS ANGELES, Oct. 1, 2026 /PRNewswire/ -- Momcozy, a leading global brand supporting women and families through pregnancy and motherhood, has partnered with Postpartum Support International (PSI) to establish a $100,000 scholarship fund designed to expand access to professional perinatal mental h...

2026-10-02 00:00 2928

Five Years of Purposeful Fashion: LILYSILK Renews Partnership with National Breast Cancer Foundation for 'A Bloom of Care' Campaign

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- LILYSILK, the world's leading silk brand dedicated to inspiring people to live spectacularly, announced the renewal of its partnership withNational Breast Cancer Foundation, Inc.® (NBCF) through a new campaign, "A Bloo...

2026-10-01 22:00 4975

Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data

First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration subcutaneous formulation designed to combine BBT001's emerging profile of rapid, deep and durable clinical activity with convenient administration a...

2026-10-01 21:00 2794

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...

2026-10-01 19:00 2679

Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance

AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., Sept. 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform co...

2026-10-01 04:00 6214
12345 ... 329